4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000098
Director sold 92,500 shares at $20.50 ($1,896,250)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-01 | Sale : show line 1 in the form 10b5-1 | −92,500 | $20.50 | $1,896,250 | 47,341 | D |
| Open-market sales · 92,500 sh · avg $20.50 · $1,896,250 | ||||||
Loading xslF345X05/wk-form4_1712095651.xml…